Related Experiment Video
Updated: Aug 9, 2025

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models
Sang Youb Han1, Jung Yeon Ghee2, Jin Joo Cha2
1Department of Internal Medicine, Inje University, Ilsan-Paik Hospital, Goyang 10380, Republic of Korea.
Abstract:
V-set Ig domain-containing 4 (VSIG4) regulates an inflammatory response and is involved in various diseases. However, the role of VSIG4 in kidney diseases is still unclear. Here, we investigated VSIG4 expression in unilateral ureteral obstruction (UUO), doxorubicin-induced kidney injury mouse, and doxorubicin-induced podocyte injury models. The levels of urinary VSIG4 protein significantly increased in the UUO mice compared with that in the control. The expression of VSIG4 mRNA and protein in the UUO mice was significantly upregulated compared with that in the control. In the doxorubicin-induced kidney injury model, the levels of urinary albumin and VSIG4 for 24 h were significantly higher than those in the control mice. Notably, a significant correlation was observed between urinary levels of VSIG4 and albumin (r = 0.912, p < 0.001). Intrarenal VSIG4 mRNA and protein expression were also significantly higher in the doxorubicin-induced mice than in the control. In cultured podocytes, VSIG4 mRNA and protein expressions were significantly higher in the doxorubicin-treated groups (1.0 and 3.0 μg/mL) than in the controls at 12 and 24 h. In conclusion, VSIG4 expression was upregulated in the UUO and doxorubicin-induced kidney injury models. VSIG4 may be involved in pathogenesis and disease progression in chronic kidney disease models.
Insights
V-set Ig domain-containing 4 (VSIG4) protein and mRNA expression increased in mouse models of kidney injury. This suggests VSIG4 may play a role in the progression of chronic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- V-set Ig domain-containing 4 (VSIG4) is known to regulate inflammatory responses and is implicated in various diseases.
- The specific role of VSIG4 in the context of kidney diseases remains largely unexplored.
Purpose of the Study:
- To investigate the expression and potential role of VSIG4 in different models of kidney injury.
- To determine if VSIG4 is upregulated in response to kidney damage and if it correlates with disease markers.
Main Methods:
- Utilized unilateral ureteral obstruction (UUO) and doxorubicin-induced kidney injury mouse models.
- Examined VSIG4 mRNA and protein expression in kidney tissues and urinary samples.
- Assessed VSIG4 levels in cultured podocytes subjected to doxorubicin treatment.
- Correlated urinary VSIG4 levels with urinary albumin levels.
Main Results:
- Urinary VSIG4 protein levels were significantly elevated in UUO mice compared to controls.
- Both mRNA and protein expression of VSIG4 were upregulated in the kidneys of UUO mice.
- In doxorubicin-induced kidney injury, urinary VSIG4 and albumin levels were significantly increased.
- A strong positive correlation was found between urinary VSIG4 and albumin levels (r = 0.912, p < 0.001).
- Intrarenal VSIG4 expression and podocyte VSIG4 expression were upregulated following doxorubicin treatment.
Conclusions:
- VSIG4 expression is upregulated in both UUO and doxorubicin-induced kidney injury models.
- These findings suggest that VSIG4 may be involved in the pathogenesis and progression of chronic kidney disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Chronic Kidney Disease IV: Nursing Management

